To investigate whether the Ras/ERK signaling pathway mediates the functional effects of HOXB7 in BC cells, the ERK1/2-specific activator Ro67–7476 and the MEK inhibitor PD98059 were used for rescue experiments in 5637 and T24 cells. Here, HOXB7 is linked to breast cancer.